Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Strazzabosco

Showing results (11-20 of 177) with videos related to

Pageof 18
Sort By:
Clinical Liver Disease|May 2, 2019
Cystic Fibrosis-Related Liver Diseases: New Paradigm for Treatment Based on PathophysiologyRomina Fiorotto, Mario Strazzabosco
Journal of Hepatology|August 21, 2012
The balance between Notch/Wnt signaling regulates progenitor cells' commitment during liver repair: mystery solved?Mario Strazzabosco, Luca Fabris
Seminars in Liver Disease|February 24, 2011
Epithelial-mesenchymal interactions in biliary diseasesLuca Fabris, Mario Strazzabosco
Journal of Hepatology|January 17, 2012
Development of the bile ducts: essentials for the clinical hepatologistMario Strazzabosco, Luca Fabris
Anatomical Record (Hoboken, N.J. : 2007)|May 20, 2008
Functional anatomy of normal bile ductsMario Strazzabosco, Luca Fabris
Hepatobiliary Surgery and Nutrition|February 27, 2014
Vascular endothelial growth factors in progenitor cells mediated liver repairCarlo Spirli, Mario Strazzabosco
Hepatology (Baltimore, Md.)|June 17, 2014
Emerging roles of Notch signaling in liver diseaseFabian Geisler, Mario Strazzabosco
Translational Gastroenterology and Hepatology|April 7, 2021
Rare and undiagnosed liver diseases: challenges and opportunitiesLuca Fabris, Mario Strazzabosco
Hepatology (Baltimore, Md.)|August 6, 2013
Healthcare costs associated with hepatocellular carcinoma and the value of careLorenzo G Mantovani, Mario Strazzabosco
Journal of Clinical Gastroenterology|August 2, 2007
Hepatic venous pressure gradient (HVPG), serum sodium (SNa), and model of end-stage liver disease score (MELD): prognostic significance and correlationsTamar H Taddei, Mario Strazzabosco
Pageof 18

Showing results (11-20 of 177) with videos related to

Sort By:
Pageof 18
Clinical Liver Disease|May 2, 2019
Cystic Fibrosis-Related Liver Diseases: New Paradigm for Treatment Based on PathophysiologyRomina Fiorotto, Mario Strazzabosco
Journal of Hepatology|August 21, 2012
The balance between Notch/Wnt signaling regulates progenitor cells' commitment during liver repair: mystery solved?Mario Strazzabosco, Luca Fabris
Seminars in Liver Disease|February 24, 2011
Epithelial-mesenchymal interactions in biliary diseasesLuca Fabris, Mario Strazzabosco
Journal of Hepatology|January 17, 2012
Development of the bile ducts: essentials for the clinical hepatologistMario Strazzabosco, Luca Fabris
Anatomical Record (Hoboken, N.J. : 2007)|May 20, 2008
Functional anatomy of normal bile ductsMario Strazzabosco, Luca Fabris
Hepatobiliary Surgery and Nutrition|February 27, 2014
Vascular endothelial growth factors in progenitor cells mediated liver repairCarlo Spirli, Mario Strazzabosco
Hepatology (Baltimore, Md.)|June 17, 2014
Emerging roles of Notch signaling in liver diseaseFabian Geisler, Mario Strazzabosco
Translational Gastroenterology and Hepatology|April 7, 2021
Rare and undiagnosed liver diseases: challenges and opportunitiesLuca Fabris, Mario Strazzabosco
Hepatology (Baltimore, Md.)|August 6, 2013
Healthcare costs associated with hepatocellular carcinoma and the value of careLorenzo G Mantovani, Mario Strazzabosco
Journal of Clinical Gastroenterology|August 2, 2007
Hepatic venous pressure gradient (HVPG), serum sodium (SNa), and model of end-stage liver disease score (MELD): prognostic significance and correlationsTamar H Taddei, Mario Strazzabosco
Pageof 18